• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于靶向基因治疗的聚乙二醇化腺病毒

PEGylated adenovirus for targeted gene therapy.

作者信息

O'Riordan Catherine R, Song Antonius

机构信息

Genzyme Corporation, Framingham, MA, USA.

出版信息

Methods Mol Biol. 2008;434:133-60. doi: 10.1007/978-1-60327-248-3_9.

DOI:10.1007/978-1-60327-248-3_9
PMID:18470643
Abstract

Bifunctional polyethylene glycol (PEG) molecules provide a novel approach to retargeting viral vectors without the need to genetically modify the vector. Modification of the surface of adenovirus with heterofunctional PEG allows further modification of the capsid with ligands. In addition, heterofunctional PEG modification ablates the normal tropism of the virus and reduces transduction of non-target tissues in vivo. Moreover, the addition of PEG chains to the surface of the virus shields antigen-binding sites, significantly reducing the susceptibility of the virus to antibody neutralization. Finally, T cell subsets from mice exposed to the PEGylated vector demonstrate a marked decrease in Th1 and Th2 responses, suggesting that PEG modification may help reduce the immune response to the vector.

摘要

双功能聚乙二醇(PEG)分子提供了一种无需对载体进行基因改造即可重新靶向病毒载体的新方法。用异功能PEG修饰腺病毒表面,可进一步用配体修饰衣壳。此外,异功能PEG修饰消除了病毒的正常嗜性,并减少了体内非靶组织的转导。而且,在病毒表面添加PEG链可屏蔽抗原结合位点,显著降低病毒对抗体中和的敏感性。最后,暴露于聚乙二醇化载体的小鼠的T细胞亚群显示Th1和Th2反应明显降低,这表明PEG修饰可能有助于降低对载体的免疫反应。

相似文献

1
PEGylated adenovirus for targeted gene therapy.用于靶向基因治疗的聚乙二醇化腺病毒
Methods Mol Biol. 2008;434:133-60. doi: 10.1007/978-1-60327-248-3_9.
2
Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates.使用异功能聚乙二醇FGF2偶联物靶向腺病毒载体。
Mol Ther. 2003 Jul;8(1):99-107. doi: 10.1016/s1525-0016(03)00139-4.
3
Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.通过全身给药使用聚乙二醇化腺病毒载体进行有效的肿瘤靶向基因转移。
J Control Release. 2007 Sep 11;122(1):102-10. doi: 10.1016/j.jconrel.2007.06.010. Epub 2007 Jun 21.
4
Development of PEGylated adenovirus vector with targeting ligand.具有靶向配体的聚乙二醇化腺病毒载体的开发。
Int J Pharm. 2008 Apr 16;354(1-2):3-8. doi: 10.1016/j.ijpharm.2007.08.025. Epub 2007 Aug 24.
5
Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.评估聚乙二醇对第一代腺病毒载体和辅助依赖型腺病毒载体的修饰以降低先天性免疫反应。
Mol Ther. 2005 Jan;11(1):66-79. doi: 10.1016/j.ymthe.2004.09.015.
6
Folate immobilized and PEGylated adenovirus for retargeting to tumor cells.用于重新靶向肿瘤细胞的叶酸固定化聚乙二醇化腺病毒。
Bioconjug Chem. 2006 May-Jun;17(3):721-7. doi: 10.1021/bc060030c.
7
Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor.光化学增强靶向表皮生长因子受体的聚合物复合腺病毒的转导作用
J Gene Med. 2006 Mar;8(3):286-97. doi: 10.1002/jgm.853.
8
Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides.还原胺化作为一种通过用大型多糖进行化学衣壳修饰来降低腺病毒载体混杂性的策略。
J Gene Med. 2008 Dec;10(12):1303-14. doi: 10.1002/jgm.1262.
9
Optimization and internalization mechanisms of PEGylated adenovirus vector with targeting peptide for cancer gene therapy.靶向肽修饰的聚乙二醇化腺病毒载体用于癌症基因治疗的优化及其内化机制。
Biomacromolecules. 2012 Aug 13;13(8):2402-9. doi: 10.1021/bm300665u. Epub 2012 Jul 23.
10
Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.用生物筛选肽修饰腺病毒载体:一种向特定细胞进行基因递送的新策略。
Hum Gene Ther. 1999 Nov 1;10(16):2615-26. doi: 10.1089/10430349950016654.

引用本文的文献

1
Designer Oncolytic Adenovirus: Coming of Age.设计型溶瘤腺病毒:走向成熟
Cancers (Basel). 2018 Jun 14;10(6):201. doi: 10.3390/cancers10060201.
2
Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells.用于靶向抗原呈递细胞的纳米颗粒上的DNA展示
ACS Biomater Sci Eng. 2017 Apr 10;3(4):496-501. doi: 10.1021/acsbiomaterials.7b00148. Epub 2017 Mar 14.
3
Increasing the efficacy of oncolytic adenovirus vectors.提高溶瘤腺病毒载体的疗效。
Viruses. 2010 Sep;2(9):1844-1866. doi: 10.3390/v2091844. Epub 2010 Aug 27.
4
PEGylated Adenoviruses: From Mice to Monkeys.聚乙二醇化腺病毒:从鼠到人。
Viruses. 2010 Feb;2(2):468-502. doi: 10.3390/v2020468. Epub 2010 Feb 1.
5
Current progress in the development of a prophylactic vaccine for HIV-1.HIV-1预防性疫苗研发的当前进展。
Drug Des Devel Ther. 2010 Dec 22;5:9-26. doi: 10.2147/DDDT.S6959.
6
Strategies to overcome host immunity to adenovirus vectors in vaccine development.疫苗研发中克服宿主对腺病毒载体免疫的策略。
Expert Rev Vaccines. 2009 Jun;8(6):761-77. doi: 10.1586/erv.09.29.